diatrizoate meglumine/iodipamide (Sinografin)

Introduction

Tradename: Sinografin.

Indications

• radiopaque agent use to visualize the uterus

Dosage

Solution: -diatrizoate meglumine 527 mg & Iodipamide meglumine 268 mg/mL (10 mL)

Adverse effects

• anaphylactoid reaction 1-10%
• (see diatrizoate)

More general terms

• pharmacologic combination

Components

• diatrizoate